Transformation of Organic Matter of the Larch Forest Soils in the Northern Taiga of Nizhne-Tungusskoe Plateau, Central Siberia

The evaluation of biospheric role of the boreal forests in the accumulation of carbon is connected with the evaluation of organic matter (OM) pool in soils. The research sites were larch forests, they are situated on Nizhne-Tungusskoe Plateau. Larch forests of feather-moss and lichen types (110 and 380 years old) were formed on 'ochric podbur' soils. Litter stocks are 3.5–4.5 kg m^{− 2} with thickness 10–25 cm. Cryomezomorphic northern taiga soils contains 38–73 t (carbon) ha^{− 1}. Pool of fast mineralized OM has average value 38.1 t (carbon) ha^{− 1}, including 20.5 and 6.4 t (Carbon) ha^{− 1} of labile compounds on surface and in the soil, and 11.2 t (carbon) ha^{− 1} of mobile OM. Microbial mass reaches 1.78–3.47 t (carbon) ha^{− 1}, its proportion is 3.6–4.9% of the total OM carbon. Zoomass of feather-moss larch forest is 0.20–0.61 * 10^{− 2}, in lichen larch forest −0.01–0.07 * 10^{− 2} t (carbon) ha^{− 1}. A pool of resistant to biological decomposition and bonded to mineral soil matrix OM is 17.7 t (carbon) ha^{− 1} and it varies from 18.6 to 29.0 in feather-moss larch forest, and from 6.4 to 17.0 t (carbon) ha^{− 1} in lichen larch forest. Two-years field experiment has been performed to determine transformation rates of various plant litter fractions and to clarify the role of soil biota in these processes. The results showed participation of all biota groups in the decomposition of plant residues caused weight loss of larch-needles and root mortmass. Isolation of organic matter from all-size invertebrate groups leads to some decrease of decomposition activity.     

Incremental cost-effectiveness of incorporating oestriol evaluation in down syndrome screening programmes

As screening for Down syndrome becomes increasingly sophisticated, it is important to evaluate the newer technologies in terms of their cost-effectiveness. One recent addition to Down syndrome screening programmes is maternal serum unconjugated oestriol (uE₃), especially when used in conjunction with maternal serum α-fetoprotein and human chorionic gonadotropin. Using assumptions used in a California proposal to justify an expanded screening programme for Down syndrome, we calculated both the average and the incremental cost-effectiveness of adding uE₃. Using the base case assumptions, including an $8 fee for the uE₃, the incremental cost-effectiveness of adding uE₃ to the proposed California programme is $119 100 per case detected, a value that compares favourably with other Down syndrome screening programmes. The sensitivity analysis supports this conclusion over a wide range of assumptions. However, because of the uncertainty with some key data, it is still too early to fully support the inclusion of uE₃ in Down syndrome screening programmes.     

Prenatal diagnosis and outcomes of five cases of mosaicism for an isochromosome of 20q

Five cases of mosaicism for an isochromosome of 20q have been detected from a total of 50 000 cases analysed for prenatal diagnosis by amniocentesis. Karyotypes were designated mos 46,X_/46,X_,i(20q). In all cases, the abnormal cell line was detected in more than one primary culture, thus fulfilling the criterion for true (level III) mosaicism. Indications for prenatal diagnosis were parental anxiety (two cases), low maternal serum alpha-fetoprotein (AFP) (two cases), and high maternal serum AFP (one case). Level II ultrasounds on all five fetuses were normal, and the abnormal cell line was never detected in fetal blood and/or cord blood. All five pregnancies were continued and had normal outcomes, with birth weights ranging from 2.4 to 3.8 kg. The development of all five children has been normal, with the oldest child in the study now 4 years of age. We suggest that the abnormal cell line in each case was of extrafetal origin, and that this may be one of the more common examples of this phenomenon, occurring in approximately 1/10000 prenatal diagnoses. Mosaicism i(20q) may have been missed in the past because of the higher resolution necessary to detect this subtle change.     

Introduction of early amniocentesis to routine prenatal diagnosis

With growing awareness of the problems associated with prenatal cytogenetic diagnoses after CVS, attempts have been made to provide early amniocentesis as an alternative to CVS. Since 1990, at our clinic the gestational age limit for routine diagnostic amniocentesis has been successively lowered, first to 14 and then to 13 weeks of gestation. Thus, 811 prenatal diagnoses were performed after early amniocentesis at 13 weeks (n = 217) and at 14 weeks of gestation (n = 594). No problems were encountered. Culture failure was never observed in the early samples. Using the criteria ‘number of colonies’ and ‘culture duration until harvest’, early samples taken at 14 weeks did not differ significantly from the controls after standard amniocentesis performed at 15 and 16 weeks, respectively, whereas a minority of samples taken at 13 weeks experienced some delay in culturing. However, in each group at least 85 per cent of samples led to a diagnosis fulfilling our standard criteria of a safe diagnosis (at least 20 metaphases of at least five colonies from at least one primary culture after trypsinization) within 15 days. Some differences between the different groups can be recognized: culture duration of less than 11 days tends to be increasing after standard amniocentesis, whereas long culture duration (more than 20 days) is more often associated with early amniocentesis. However, this trend is only minimal and did not result in an increased risk of missing a diagnosis.     

Limb reduction and chorion villus sampling

Upper limb reduction was diagnosed by ultrasound scan at 17 weeks after chorion villus sampling at 9 weeks' gestation. Pregnancy was terminated and necropsy confirmed limb reduction in an otherwise normal fetus. The relationship of limb reduction to amniotic band syndrome is discussed.